Labeler
Cipla USA Inc. NDC Codes
Cipla USA Inc. lists 269 finished drug products in the FDA NDC Directory under NDC labeler code 69097.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lanreotide Acetate, Diltiazem Hydrochloride, Lenalidomide, Lurasidone Hydrochloride, Pomalidomide, Phytonadione, Pravastatin Sodium, Fluticasone propionate and Salmeterol, Nilotinib, Potassium Phosphates, Vilazodone Hydrochloride, Pirfenidone, Deferasirox, Lanthanum carbonate, Dapagliflozin
- Active ingredients
- Lanreotide acetate, Diltiazem hydrochloride, Lenalidomide, Lurasidone hydrochloride, Pomalidomide, Phytonadione, Pravastatin sodium, Fluticasone propionate, Salmeterol xinafoate, Nilotinib, Monobasic potassium phosphate, Dibasic potassium phosphate
- NDC labeler codes
- 69097
- Strengths (from the 100 most recently listed products)
- Salmeterol xinafoate 50 ug/1; Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL; Liraglutide 6 mg/mL; Lanreotide acetate 120 mg/.5mL; Lanreotide acetate 60 mg/.2mL; Lanreotide acetate 90 mg/.3mL; Phytonadione 1 mg/.5mL; Pirfenidone 267 mg/1; Cyclosporine .5 mg/mL; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Fluticasone propionate 250 ug/1; Fluticasone propionate 100 ug/1; Fluticasone propionate 500 ug/1; Albuterol sulfate 90 ug/1; Dapagliflozin propanediol 5 mg/1; Dapagliflozin propanediol 10 mg/1
- Dosage forms
- Capsule, Tablet, Film coated, Injection, Tablet, Tablet, Extended release, Powder, Injection, Solution, Injection, Emulsion, For suspension, Granule, Tablet, Chewable, Emulsion, Kit, Suspension, Tablet, Film coated, Extended release, Tablet, Coated, Aerosol, Metered, Injection, Powder, Lyophilized, For suspension, Gel, Granule, For solution, Solution
- Routes
- Oral, Subcutaneous, Intravenous, Intramuscular, Respiratory (Inhalation), Ophthalmic, Topical
- Drug classes (FDA established)
- Thalidomide Analog, Somatostatin Analog, Osmotic Laxative, Potassium Salt, Calcium Channel Blocker, beta2-Adrenergic Agonist, Kinase Inhibitor, Atypical Antipsychotic, Corticosteroid, Vitamin K, Warfarin Reversal Agent, HMG-CoA Reductase Inhibitor, Proton Pump Inhibitor, Protease Inhibitor, Pyridone, Iron Chelator, Phosphate Binder, Sodium-Glucose Cotransporter 2 Inhibitor, GLP-1 Receptor Agonist, Leukocyte Growth Factor, P2Y12 Platelet Inhibitor, Serotonin Reuptake Inhibitor, Serotonin-4 Receptor Agonist, Dihydropyridine Calcium Channel Blocker, Aminoketone, Androgen, Nucleoside Metabolic Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Calcineurin Inhibitor Immunosuppressant, Microtubule Inhibitor, Penicillin-class Antibacterial, beta Lactamase Inhibitor, Calcitonin, Nonsteroidal Anti-inflammatory Drug, Muscle Relaxant, Neuraminidase Inhibitor, Cytochrome P450 3A Inhibitor, Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Cyclosporine | Cyclosporine .5 mg/mL | EmulsionOphthalmic | 69097-292 | 69097-0292-0369097-0292-97 | — |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | 69097-036 | 69097-0036-0769097-0036-81 | — |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | 69097-037 | 69097-0037-0769097-0037-81 | — |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | 69097-038 | 69097-0038-0769097-0038-81 | — |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | 69097-039 | 69097-0039-0769097-0039-81 | — |
| Fluticasone propionate and Salmeterol | Fluticasone propionate 250 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 69097-661 | 69097-0661-03 | — |
| Fluticasone propionate and Salmeterol | Fluticasone propionate 100 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 69097-662 | 69097-0662-03 | — |
| Fluticasone propionate and Salmeterol | Fluticasone propionate 500 ug/1; Salmeterol xinafoate 50 ug/1 | PowderRespiratory (Inhalation) | 69097-663 | 69097-0663-03 | — |
| Albuterolalbuterol sulfate | Albuterol sulfate 90 ug/1 | Aerosol, MeteredRespiratory (Inhalation) | 69097-021 | 69097-0021-60 | — |
| Dapagliflozin | Dapagliflozin propanediol 5 mg/1 | Tablet, Film coatedOral | 69097-388 | 69097-0388-02 | — |
| Dapagliflozin | Dapagliflozin propanediol 10 mg/1 | Tablet, Film coatedOral | 69097-389 | 69097-0389-02 | — |
| Nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | 69097-639 | 69097-0639-03 | — |
| Nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | 69097-641 | 69097-0641-03 | — |
| liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | 69097-910 | 69097-0910-5569097-0910-68 | — |
| Nypozifilgrastim-txid | Filgrastim 480 ug/480ug | InjectionIntravenous, Subcutaneous | 69097-429 | 69097-0429-6769097-0429-96 | — |
| Nypozifilgrastim-txid | Filgrastim 300 ug/300ug | InjectionIntravenous, Subcutaneous | 69097-430 | 69097-0430-6769097-0430-96 | — |
| Liraglutide | Liraglutide 6 mg/mL | Injection, SolutionSubcutaneous | 69097-920 | 69097-0920-6769097-0920-68 | — |
| Ticagrelor | Ticagrelor 60 mg/1 | Tablet, Film coatedOral | 69097-989 | 69097-0989-0369097-0989-0769097-0989-12 | — |
| Glucagon | — | Kit | 69097-027 | 69097-0027-50 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 150 mg/1 | CapsuleOral | 69097-438 | 69097-0438-02 | — |
| Sertraline Hydrochloride | Sertraline hydrochloride 200 mg/1 | CapsuleOral | 69097-451 | 69097-0451-02 | — |
| Prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | 69097-218 | 69097-0218-02 | — |
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | 69097-219 | 69097-0219-02 | — |
| Nilotinib | Nilotinib 50 mg/1 | CapsuleOral | 69097-030 | 69097-0030-0869097-0030-63 | — |
| Nilotinib | Nilotinib 150 mg/1 | CapsuleOral | 69097-031 | 69097-0031-7469097-0031-91 | — |
| Nilotinib | Nilotinib 200 mg/1 | CapsuleOral | 69097-032 | 69097-0032-7469097-0032-91 | — |
| Lanreotide Acetate | Lanreotide acetate 120 mg/.5mL | InjectionSubcutaneous | 69097-906 | 69097-0906-67 | — |
| Lanreotide Acetate | Lanreotide acetate 60 mg/.2mL | InjectionSubcutaneous | 69097-907 | 69097-0907-67 | — |
| Lanreotide Acetate | Lanreotide acetate 90 mg/.3mL | InjectionSubcutaneous | 69097-908 | 69097-0908-67 | — |
| Ticagrelor | Ticagrelor 90 mg/1 | Tablet, Film coatedOral | 69097-991 | 69097-0991-0369097-0991-0769097-0991-12 | — |
| Paclitaxel protein-bound particles | Paclitaxel 100 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | 69097-398 | 69097-0398-78 | — |
| PANTOPRAZOLE SODIUM DELAYED-RELEASE delayed releasepantoprazole sodium granules | Pantoprazole sodium 40 mg/1 | SuspensionOral | 69097-531 | 69097-0531-53 | — |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | InjectionIntravenous | 69097-055 | 69097-0055-97 | — |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | InjectionIntravenous | 69097-077 | 69097-0077-97 | — |
| Potassium Phosphates | Monobasic potassium phosphate 224 mg/mL; Dibasic potassium phosphate 236 mg/mL | InjectionIntravenous | 69097-078 | 69097-0078-97 | — |
| Phytonadione | Phytonadione 1 mg/.5mL | Injection, EmulsionIntramuscular, Intravenous, Subcutaneous | 69097-003 | 69097-0003-96 | — |
| Esomeprazole magnesium | Esomeprazole magnesium dihydrate 2.5 mg/1 | For suspensionOral | 69097-507 | 69097-0507-31 | — |
| Esomeprazole magnesium | Esomeprazole magnesium dihydrate 5 mg/1 | For suspensionOral | 69097-508 | 69097-0508-31 | — |
| Amoxicillin and Clavulanate potassium | Amoxicillin 250 mg/5mL; Clavulanate potassium 62.5 mg/5mL | SuspensionOral | 69097-098 | 69097-0098-0869097-0098-4369097-0098-44 | — |
| Calcitonin Salmon | Calcitonin salmon 200 [USP'U]/mL | Injection, SolutionIntramuscular, Subcutaneous | 69097-770 | 69097-0770-32 | — |
| Nicardipine Hydrochloride | Nicardipine hydrochloride .1 mg/mL | InjectionIntravenous | 69097-007 | 69097-0007-22 | — |
| Nicardipine Hydrochloride | Nicardipine .2 mg/mL | InjectionIntravenous | 69097-008 | 69097-0008-22 | — |
| Hydrocortisone sodium succinate | Hydrocortisone sodium succinate 100 mg/2mL | InjectionIntramuscular, Intravenous | 69097-004 | 69097-0004-67 | — |
| Diclofenac sodium | Diclofenac sodium 10 mg/g | GelTopical | 69097-720 | 69097-0720-44 | — |
| Pravastatin Sodium | Pravastatin sodium 10 mg/1 | TabletOral | 69097-788 | 69097-0788-0569097-0788-12 | — |
| Pravastatin Sodium | Pravastatin sodium 20 mg/1 | TabletOral | 69097-789 | 69097-0789-0569097-0789-12 | — |
| Pravastatin Sodium | Pravastatin sodium 40 mg/1 | TabletOral | 69097-791 | 69097-0791-0569097-0791-12 | — |
| Pravastatin Sodium | Pravastatin sodium 80 mg/1 | TabletOral | 69097-792 | 69097-0792-0569097-0792-12 | — |
| Phytonadione | Phytonadione 5 mg/1 | TabletOral | 69097-999 | 69097-0999-0269097-0999-07 | — |
| Darunavir 600 and 800 mgdarunavir | Darunavir hydrate 800 mg/1 | TabletOral | 69097-244 | 69097-0244-02 | — |
Cipla USA Inc.: common questions
- What is Cipla USA Inc.'s NDC labeler code?
- 69097. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Cipla USA Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.